North America Immuno Chemistry Market Outlook to 2024

Published : Dec-2017

No. of Pages : 459

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 7
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Immuno Chemistry Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 12
3 Immuno Chemistry Market, North America 16
3.1 Immuno Chemistry Market, North America, Revenue ($m), 2010-2024 16
3.2 Immuno Chemistry Market, North America, Category Comparison by Revenue ($m), 2010-2024 18
3.3 Immuno Chemistry Market, North America, Revenue ($m), 2010-2017 20
3.4 Immuno Chemistry Market, North America, Revenue ($m), 2017-2024 22
3.5 Immuno Chemistry Market, North America, Volume (Units), 2010-2024 24
3.6 Immuno Chemistry Market, North America, Volume (Units), 2010-2017 26
3.7 Immuno Chemistry Market, North America, Volume (Units), 2017-2024 28
3.8 Immuno Chemistry Market, North America, Company Share by Revenue ($m), 2017 30
4 Immuno Chemistry Market, Canada 32
4.1 Immuno Chemistry Market, Canada, Revenue ($m), 2010-2017 32
4.2 Immuno Chemistry Market, Canada, Revenue ($m), 2017-2024 34
4.3 Immuno Chemistry Market, Canada, Volume (Units), 2010-2017 68
4.4 Immuno Chemistry Market, Canada, Volume (Units), 2017-2024 70
4.5 Immuno Chemistry Market, Canada, Average Price ($), 2010-2024 104
4.6 Immuno Chemistry Market, Canada, Distribution Share by Revenue ($m), 2017 108
4.7 Immuno Chemistry Market, Canada, Company Share by Revenue ($m), 2017 109
5 Immuno Chemistry Market, Mexico 111
5.1 Immuno Chemistry Market, Mexico, Revenue ($m), 2010-2017 111
5.2 Immuno Chemistry Market, Mexico, Revenue ($m), 2017-2024 113
3.3 Immuno Chemistry Market, Mexico, Volume (Units), 2010-2017 147
3.4 Immuno Chemistry Market, Mexico, Volume (Units), 2017-2024 149
5.5 Immuno Chemistry Market, Mexico, Average Price ($), 2010-2024 183
5.6 Immuno Chemistry Market, Mexico, Distribution Share by Revenue ($m), 2017 187
5.7 Immuno Chemistry Market, Mexico, Company Share by Revenue ($m), 2017 188
6 Immuno Chemistry Market, United States 190
6.1 Immuno Chemistry Market, United States, Revenue ($m), 2010-2017 190
6.2 Immuno Chemistry Market, United States, Revenue ($m), 2017-2024 192
6.3 Immuno Chemistry Market, United States, Volume (Units), 2010-2017 226
6.4 Immuno Chemistry Market, United States, Volume (Units), 2017-2024 228
6.5 Immuno Chemistry Market, United States, Average Price ($), 2010-2024 262
6.6 Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), 2017 266
6.7 Immuno Chemistry Market, United States, Company Share by Revenue ($m), 2017 267
7 Overview of Key Companies in North America Immuno Chemistry Market 269
7.1 Siemens Healthcare GmbH 269
7.2 F. Hoffmann-La Roche Ltd 269
7.3 Abbott Laboratories 269
7.4 Beckman Coulter Inc 269
7.5 Thermo Fisher Scientific Inc 270
7.6 Ortho-Clinical Diagnostics Inc 270
7.7 Bio-Rad Laboratories Inc 270
7.8 DiaSorin S.p.A 270
7.9 bioMerieux SA 271
7.10 Alere Inc 271
8 Immuno Chemistry Market Pipeline Products 272
9 Recent Developments 278
9.1 Corporate Communications 278
9.2 Financial Announcements 310
9.3 Government and Public Interest 415
9.4 Legal And Regulatory 417
9.5 Other Significant Developments 425
9.6 Product News 434
9.7 Strategy And Business Planning 442
10 Appendix 446
10.1 Research Methodology 447
10.2 GlobalData Consulting 451
10.3 Contact Us 452
10.4 Disclaimer 452

1.1 List of Tables
Table 1: Immuno Chemistry Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 24
Table 2: Immuno Chemistry Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 26
Table 3: Immuno Chemistry Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 28
Table 4: Immuno Chemistry Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 30
Table 5: Immuno Chemistry Market, North America, Volume (Units), 2010-2024 32
Table 6: Immuno Chemistry Market, North America, Volume (Units), Historic, 2010-2017 34
Table 7: Immuno Chemistry Market, North America, Volume (Units), Forecast, 2017-2024 36
Table 8: Immuno Chemistry Market, North America, Company Share by Revenue ($m), USD Constant, 2017 38
Table 9: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 40
Table 10: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Table 11: Complement Deficiency Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 44
Table 12: Diabetes Assays Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 46
Table 13: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 48
Table 14: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 50
Table 15: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 52
Table 16: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 54
Table 17: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 56
Table 18: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 58
Table 19: Complement Deficiency Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 60
Table 20: Diabetes Assays Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 62
Table 21: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 64
Table 22: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 66
Table 23: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 68
Table 24: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 70
Table 25: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 72
Table 26: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 74
Table 27: Immuno Chemistry Market, Canada, Volume (Units), Historic, 2010-2017 76
Table 28: Immuno Chemistry Market, Canada, Volume (Units), Forecast, 2017-2024 78
Table 29: Complement Deficiency Tests Market, Canada, Volume (Units), Historic, 2010-2017 80
Table 30: Diabetes Assays Market, Canada, Volume (Units), Historic, 2010-2017 82
Table 31: Disease Specific Immunochemistry Market, Canada, Volume (Units), Historic, 2010-2017 84
Table 32: Endocrinology Tests Market, Canada, Volume (Units), Historic, 2010-2017 86
Table 33: IgE Allergy Blood Tests Market, Canada, Volume (Units), Historic, 2010-2017 88
Table 34: Immunochemistry Analyzers Market, Canada, Volume (Units), Historic, 2010-2017 90
Table 35: Immunochemistry Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 92
Table 36: Vitamins Tests Market, Canada, Volume (Units), Historic, 2010-2017 94
Table 37: Complement Deficiency Tests Market, Canada, Volume (Units), Forecast, 2017-2024 96
Table 38: Diabetes Assays Market, Canada, Volume (Units), Forecast, 2017-2024 98
Table 39: Disease Specific Immunochemistry Market, Canada, Volume (Units), Forecast, 2017-2024 100
Table 40: Endocrinology Tests Market, Canada, Volume (Units), Forecast, 2017-2024 102
Table 41: IgE Allergy Blood Tests Market, Canada, Volume (Units), Forecast, 2017-2024 104
Table 42: Immunochemistry Analyzers Market, Canada, Volume (Units), Forecast, 2017-2024 106
Table 43: Immunochemistry Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 108
Table 44: Vitamins Tests Market, Canada, Volume (Units), Forecast, 2017-2024 110
Table 45: Immuno Chemistry Market, Canada, Average Price ($) Historic, 2010-2017 111
Table 46: Immuno Chemistry Market, Canada, Average Price ($), Forecast, 2017-2024 113
Table 47: Immuno Chemistry Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 115
Table 48: Immuno Chemistry Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 117
Table 49: Immuno Chemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 119
Table 50: Immuno Chemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 121
Table 51: Complement Deficiency Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 123
Table 52: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 125
Table 53: Disease Specific Immunochemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 127
Table 54: Endocrinology Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 129
Table 55: IgE Allergy Blood Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 131
Table 56: Immunochemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 133
Table 57: Immunochemistry Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 135
Table 58: Vitamins Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 137
Table 59: Complement Deficiency Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 139
Table 60: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 141
Table 61: Disease Specific Immunochemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 143
Table 62: Endocrinology Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 145
Table 63: IgE Allergy Blood Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 147
Table 64: Immunochemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 149
Table 65: Immunochemistry Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 151
Table 66: Vitamins Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 153
Table 67: Immuno Chemistry Market, Mexico, Volume (Units), Historic, 2010-2017 155
Table 68: Immuno Chemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 157
Table 69: Complement Deficiency Tests Market, Mexico, Volume (Units), Historic, 2010-2017 159
Table 70: Diabetes Assays Market, Mexico, Volume (Units), Historic, 2010-2017 161
Table 71: Disease Specific Immunochemistry Market, Mexico, Volume (Units), Historic, 2010-2017 163
Table 72: Endocrinology Tests Market, Mexico, Volume (Units), Historic, 2010-2017 165
Table 73: IgE Allergy Blood Tests Market, Mexico, Volume (Units), Historic, 2010-2017 167
Table 74: Immunochemistry Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 169
Table 75: Immunochemistry Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 171
Table 76: Vitamins Tests Market, Mexico, Volume (Units), Historic, 2010-2017 173
Table 77: Complement Deficiency Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 175
Table 78: Diabetes Assays Market, Mexico, Volume (Units), Forecast, 2017-2024 177
Table 79: Disease Specific Immunochemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 179
Table 80: Endocrinology Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 181
Table 81: IgE Allergy Blood Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 183
Table 82: Immunochemistry Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 185
Table 83: Immunochemistry Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 187
Table 84: Vitamins Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 189
Table 85: Immuno Chemistry Market, Mexico, Average Price ($) Historic, 2010-2017 190
Table 86: Immuno Chemistry Market, Mexico, Average Price ($), Forecast, 2017-2024 192
Table 87: Immuno Chemistry Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 194
Table 88: Immuno Chemistry Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 196
Table 89: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 198
Table 90: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 200
Table 91: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 202
Table 92: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 204
Table 93: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 206
Table 94: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 208
Table 95: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 210
Table 96: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 212
Table 97: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 214
Table 98: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 216
Table 99: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 218
Table 100: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 220
Table 101: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 222
Table 102: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 224
Table 103: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 226
Table 104: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 228
Table 105: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 230
Table 106: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 232
Table 107: Immuno Chemistry Market, United States, Volume (Units), Historic, 2010-2017 234
Table 108: Immuno Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 236
Table 109: Complement Deficiency Tests Market, United States, Volume (Units), Historic, 2010-2017 238
Table 110: Diabetes Assays Market, United States, Volume (Units), Historic, 2010-2017 240
Table 111: Disease Specific Immunochemistry Market, United States, Volume (Units), Historic, 2010-2017 242
Table 112: Endocrinology Tests Market, United States, Volume (Units), Historic, 2010-2017 244
Table 113: IgE Allergy Blood Tests Market, United States, Volume (Units), Historic, 2010-2017 246
Table 114: Immunochemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 248
Table 115: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 250
Table 116: Vitamins Tests Market, United States, Volume (Units), Historic, 2010-2017 252
Table 117: Complement Deficiency Tests Market, United States, Volume (Units), Forecast, 2017-2024 254
Table 118: Diabetes Assays Market, United States, Volume (Units), Forecast, 2017-2024 256
Table 119: Disease Specific Immunochemistry Market, United States, Volume (Units), Forecast, 2017-2024 258
Table 120: Endocrinology Tests Market, United States, Volume (Units), Forecast, 2017-2024 260
Table 121: IgE Allergy Blood Tests Market, United States, Volume (Units), Forecast, 2017-2024 262
Table 122: Immunochemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 264
Table 123: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 266
Table 124: Vitamins Tests Market, United States, Volume (Units), Forecast, 2017-2024 268
Table 125: Immuno Chemistry Market, United States, Average Price ($) Historic, 2010-2017 269
Table 126: Immuno Chemistry Market, United States, Average Price ($), Forecast, 2017-2024 271
Table 127: Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 273
Table 128: Immuno Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2017 275
Table 129: Immuno Chemistry Market Pipeline Products 279
Table 130: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 456

1.2 List of Figures
Figure 1: Immuno Chemistry Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 23
Figure 2: Immuno Chemistry Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 25
Figure 3: Immuno Chemistry Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 27
Figure 4: Immuno Chemistry Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 29
Figure 5: Immuno Chemistry Market, North America, Volume (Units), 2010-2024 31
Figure 6: Immuno Chemistry Market, North America, Volume (Units), Historic, 2010-2017 33
Figure 7: Immuno Chemistry Market, North America, Volume (Units), Forecast, 2017-2024 35
Figure 8: Immuno Chemistry Market, North America, Company Share (%) 2017 37
Figure 9: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 39
Figure 10: Immuno Chemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 41
Figure 11: Complement Deficiency Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 43
Figure 12: Diabetes Assays Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 45
Figure 13: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 47
Figure 14: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 49
Figure 15: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 51
Figure 16: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 53
Figure 17: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 55
Figure 18: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 57
Figure 19: Complement Deficiency Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 59
Figure 20: Diabetes Assays Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 61
Figure 21: Disease Specific Immunochemistry Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 63
Figure 22: Endocrinology Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 65
Figure 23: IgE Allergy Blood Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 67
Figure 24: Immunochemistry Analyzers Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 69
Figure 25: Immunochemistry Rapid Tests & POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 71
Figure 26: Vitamins Tests Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 73
Figure 27: Immuno Chemistry Market, Canada, Volume (Units), Historic, 2010-2017 75
Figure 28: Immuno Chemistry Market, Canada, Volume (Units), Forecast, 2017-2024 77
Figure 29: Complement Deficiency Tests Market, Canada, Volume (Units), Historic, 2010-2017 79
Figure 30: Diabetes Assays Market, Canada, Volume (Units), Historic, 2010-2017 81
Figure 31: Disease Specific Immunochemistry Market, Canada, Volume (Units), Historic, 2010-2017 83
Figure 32: Endocrinology Tests Market, Canada, Volume (Units), Historic, 2010-2017 85
Figure 33: IgE Allergy Blood Tests Market, Canada, Volume (Units), Historic, 2010-2017 87
Figure 34: Immunochemistry Analyzers Market, Canada, Volume (Units), Historic, 2010-2017 89
Figure 35: Immunochemistry Rapid Tests & POC Market, Canada, Volume (Units), Historic, 2010-2017 91
Figure 36: Vitamins Tests Market, Canada, Volume (Units), Historic, 2010-2017 93
Figure 37: Complement Deficiency Tests Market, Canada, Volume (Units), Forecast, 2017-2024 95
Figure 38: Diabetes Assays Market, Canada, Volume (Units), Forecast, 2017-2024 97
Figure 39: Disease Specific Immunochemistry Market, Canada, Volume (Units), Forecast, 2017-2024 99
Figure 40: Endocrinology Tests Market, Canada, Volume (Units), Forecast, 2017-2024 101
Figure 41: IgE Allergy Blood Tests Market, Canada, Volume (Units), Forecast, 2017-2024 103
Figure 42: Immunochemistry Analyzers Market, Canada, Volume (Units), Forecast, 2017-2024 105
Figure 43: Immunochemistry Rapid Tests & POC Market, Canada, Volume (Units), Forecast, 2017-2024 107
Figure 44: Vitamins Tests Market, Canada, Volume (Units), Forecast, 2017-2024 109
Figure 45: Immuno Chemistry Market, Canada, Company Share (%) 2017 116
Figure 46: Immuno Chemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 118
Figure 47: Immuno Chemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 120
Figure 48: Complement Deficiency Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 122
Figure 49: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 124
Figure 50: Disease Specific Immunochemistry Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 126
Figure 51: Endocrinology Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 128
Figure 52: IgE Allergy Blood Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 130
Figure 53: Immunochemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 132
Figure 54: Immunochemistry Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 134
Figure 55: Vitamins Tests Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 136
Figure 56: Complement Deficiency Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 138
Figure 57: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 140
Figure 58: Disease Specific Immunochemistry Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 142
Figure 59: Endocrinology Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 144
Figure 60: IgE Allergy Blood Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 146
Figure 61: Immunochemistry Analyzers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 148
Figure 62: Immunochemistry Rapid Tests & POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 150
Figure 63: Vitamins Tests Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 152
Figure 64: Immuno Chemistry Market, Mexico, Volume (Units), Historic, 2010-2017 154
Figure 65: Immuno Chemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 156
Figure 66: Complement Deficiency Tests Market, Mexico, Volume (Units), Historic, 2010-2017 158
Figure 67: Diabetes Assays Market, Mexico, Volume (Units), Historic, 2010-2017 160
Figure 68: Disease Specific Immunochemistry Market, Mexico, Volume (Units), Historic, 2010-2017 162
Figure 69: Endocrinology Tests Market, Mexico, Volume (Units), Historic, 2010-2017 164
Figure 70: IgE Allergy Blood Tests Market, Mexico, Volume (Units), Historic, 2010-2017 166
Figure 71: Immunochemistry Analyzers Market, Mexico, Volume (Units), Historic, 2010-2017 168
Figure 72: Immunochemistry Rapid Tests & POC Market, Mexico, Volume (Units), Historic, 2010-2017 170
Figure 73: Vitamins Tests Market, Mexico, Volume (Units), Historic, 2010-2017 172
Figure 74: Complement Deficiency Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 174
Figure 75: Diabetes Assays Market, Mexico, Volume (Units), Forecast, 2017-2024 176
Figure 76: Disease Specific Immunochemistry Market, Mexico, Volume (Units), Forecast, 2017-2024 178
Figure 77: Endocrinology Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 180
Figure 78: IgE Allergy Blood Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 182
Figure 79: Immunochemistry Analyzers Market, Mexico, Volume (Units), Forecast, 2017-2024 184
Figure 80: Immunochemistry Rapid Tests & POC Market, Mexico, Volume (Units), Forecast, 2017-2024 186
Figure 81: Vitamins Tests Market, Mexico, Volume (Units), Forecast, 2017-2024 188
Figure 82: Immuno Chemistry Market, Mexico, Company Share (%) 2017 195
Figure 83: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 197
Figure 84: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 199
Figure 85: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 201
Figure 86: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 203
Figure 87: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 205
Figure 88: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 207
Figure 89: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 209
Figure 90: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 211
Figure 91: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 213
Figure 92: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 215
Figure 93: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 217
Figure 94: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 219
Figure 95: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 221
Figure 96: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 223
Figure 97: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 225
Figure 98: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 227
Figure 99: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 229
Figure 100: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 231
Figure 101: Immuno Chemistry Market, United States, Volume (Units), Historic, 2010-2017 233
Figure 102: Immuno Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 235
Figure 103: Complement Deficiency Tests Market, United States, Volume (Units), Historic, 2010-2017 237
Figure 104: Diabetes Assays Market, United States, Volume (Units), Historic, 2010-2017 239
Figure 105: Disease Specific Immunochemistry Market, United States, Volume (Units), Historic, 2010-2017 241
Figure 106: Endocrinology Tests Market, United States, Volume (Units), Historic, 2010-2017 243
Figure 107: IgE Allergy Blood Tests Market, United States, Volume (Units), Historic, 2010-2017 245
Figure 108: Immunochemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 247
Figure 109: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 249
Figure 110: Vitamins Tests Market, United States, Volume (Units), Historic, 2010-2017 251
Figure 111: Complement Deficiency Tests Market, United States, Volume (Units), Forecast, 2017-2024 253
Figure 112: Diabetes Assays Market, United States, Volume (Units), Forecast, 2017-2024 255
Figure 113: Disease Specific Immunochemistry Market, United States, Volume (Units), Forecast, 2017-2024 257
Figure 114: Endocrinology Tests Market, United States, Volume (Units), Forecast, 2017-2024 259
Figure 115: IgE Allergy Blood Tests Market, United States, Volume (Units), Forecast, 2017-2024 261
Figure 116: Immunochemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 263
Figure 117: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 265
Figure 118: Vitamins Tests Market, United States, Volume (Units), Forecast, 2017-2024 267
Figure 119: Immuno Chemistry Market, United States, Company Share (%) 2017 274

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Hemostasis Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Hemostasis Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Hemostasis Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The increasing prevalence of surgical cases and rises in venous thromboembolism (VTE) incidence represent major driving factors for the hemostasis testing market. Prothrombin (PT) and Activated Prothrombin (aPTT) tests represent the most widely used Hemostasis tests. These devices are frequently utilized for coagulation testing prior to surgery while D-Dimer tests tend to be performed in VTE or suspected VTE cases. PT tests are also frequently used for monitoring of patients taking vitamin K antagonists such as warfarin......	$7500

North America Immuno Chemistry Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Hemostasis Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model